Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
CS Disco
LAW
$280M
| $368K | ﹤0.01% |
47,414
+349
| +0.7% | +$2.46K |
|
3977
iShares Asia 50 ETF
AIA
$5.04B
| $367K | ﹤0.01% |
3,760
+3,035
| +419% | +$293K |
|
|
PINE
3978
Alpine Income Property Trust
PINE
$346M
| $366K | ﹤0.01% |
21,893
+2,723
| +14% | +$42.5K |
|
3979
PCB Bancorp
PCB
$395M
| $366K | ﹤0.01% |
16,883
+1,572
| +10% | +$33.9K |
|
3980
Agilon Health
AGL
$1.45B
| $364K | ﹤0.01% |
21,145
+1,500
| +8% | +$29.1K |
|
3981
SmartRent
SMRT
$278M
| $364K | ﹤0.01% |
180,002
+179,986
| +1,124,913% | +$295K |
|
3982
PepGen
PEPG
$201M
| $363K | ﹤0.01% |
55,717
+54,561
| +4,720% | +$283K |
|
3983
BlackBerry
BB
$5.14B
| $362K | ﹤0.01% |
95,626
+29,989
| +46% | +$132K |
|
|
INR
3984
Infinity Natural Resources
INR
$256M
| $360K | ﹤0.01% |
24,458
+2,334
| +11% | +$30.6K |
|
3985
Genelux
GNLX
$121M
| $360K | ﹤0.01% |
+82,604
| New | +$446K |
|
3986
Lands' End
LE
$391M
| $360K | ﹤0.01% |
24,789
-2,233
| -8% | -$34.5K |
|
3987
US Gold Corp
USAU
$252M
| $359K | ﹤0.01% |
18,521
+825
| +5% | +$14.1K |
|
|
FBLA
3988
FB Bancorp
FBLA
$252M
| $359K | ﹤0.01% |
27,911
+2,767
| +11% | +$34.3K |
|
3989
Pure Cycle
PCYO
$273M
| $358K | ﹤0.01% |
32,583
+4,681
| +17% | +$52.3K |
|
3990
TFS Financial
TFSL
$4.89B
| $357K | ﹤0.01% |
26,688
+21,817
| +448% | +$299K |
|
3991
Peoples Bancorp of North Carolina
PEBK
$239M
| $357K | ﹤0.01% |
9,857
-1,149
| -10% | -$37K |
|
3992
SelectQuote
SLQT
$124M
| $356K | ﹤0.01% |
252,725
+20,893
| +9% | +$34.9K |
|
3993
Hyliion Holdings
HYLN
$694M
| $355K | ﹤0.01% |
193,155
+17,747
| +10% | +$35.7K |
|
3994
Equinor
EQNR
$97.3B
| $355K | ﹤0.01% |
+15,036
| New | +$355K |
|
3995
Health Catalyst
HCAT
$135M
| $354K | ﹤0.01% |
148,186
+10,100
| +7% | +$27.6K |
|
3996
Pangaea Logistics
PANL
$477M
| $353K | ﹤0.01% |
51,377
-9,542
| -16% | -$57.7K |
|
|
DDL
3997
Dingdong
DDL
$509M
| $352K | ﹤0.01% |
141,263
| – | – |
|
|
LNKB
3998
DELISTED
LINKBANCORP
LNKB
| $351K | ﹤0.01% |
42,545
+1,135
| +3% | +$8.53K |
|
3999
SEACOR Marine Holdings
SMHI
$264M
| $350K | ﹤0.01% |
58,185
+5,060
| +10% | +$33.4K |
|
4000
National Bankshares
NKSH
$271M
| $350K | ﹤0.01% |
10,425
+1,006
| +11% | +$30.5K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.